Sökning: WFRF:(Padmanabhan Sandosh) > TET2 and CSMD1 gene...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03626naa a2200745 4500 | |
001 | oai:lup.lub.lu.se:113f79ce-557a-44d7-afed-1dfe59fba0e9 | |
003 | SwePub | |
008 | 160401s2015 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:131177913 | |
024 | 7 | a https://lup.lub.lu.se/record/51433082 URI |
024 | 7 | a https://doi.org/10.1097/HJH.00000000000005412 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1311779132 URI |
040 | a (SwePub)lud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Chittani, Martina4 aut |
245 | 1 0 | a TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives. |
264 | 1 | c 2015 |
520 | a Thiazide diuretics have been recommended as a first-line antihypertensive treatment, although the choice of 'the right drug in the individual essential hypertensive patient' remains still empirical. Essential hypertension is a complex, polygenic disease derived from the interaction of patient's genetic background with the environment. Pharmacogenomics could be a useful tool to pinpoint gene variants involved in antihypertensive drug response, thus optimizing therapeutic advantages and minimizing side effects. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
700 | 1 | a Zaninello, Roberta4 aut |
700 | 1 | a Lanzani, Chiara4 aut |
700 | 1 | a Frau, Francesca4 aut |
700 | 1 | a Ortu, Maria F4 aut |
700 | 1 | a Salvi, Erika4 aut |
700 | 1 | a Fresu, Giovanni4 aut |
700 | 1 | a Citterio, Lorena4 aut |
700 | 1 | a Braga, Daniele4 aut |
700 | 1 | a Piras, Daniela A4 aut |
700 | 1 | a Carpini, Simona Delli4 aut |
700 | 1 | a Velayutham, Dinesh4 aut |
700 | 1 | a Simonini, Marco4 aut |
700 | 1 | a Argiolas, Giuseppe4 aut |
700 | 1 | a Pozzoli, Simona4 aut |
700 | 1 | a Troffa, Chiara4 aut |
700 | 1 | a Glorioso, Valeria4 aut |
700 | 1 | a Kontula, Kimmo K4 aut |
700 | 1 | a Hiltunen, Timo P4 aut |
700 | 1 | a Donner, Kati M4 aut |
700 | 1 | a Turner, Stephen T4 aut |
700 | 1 | a Boerwinkle, Eric4 aut |
700 | 1 | a Chapman, Arlene B4 aut |
700 | 1 | a Padmanabhan, Sandosh4 aut |
700 | 1 | a Dominiczak, Anna F4 aut |
700 | 1 | a Melander, Olleu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups4 aut0 (Swepub:lu)endo-ome |
700 | 1 | a Johnson, Julie A4 aut |
700 | 1 | a Cooper-Dehoff, Rhonda M4 aut |
700 | 1 | a Gong, Yan4 aut |
700 | 1 | a Rivera, Natalia Vu Karolinska Institutet4 aut |
700 | 1 | a Condorelli, Gianluigi4 aut |
700 | 1 | a Trimarco, Bruno4 aut |
700 | 1 | a Manunta, Paolo4 aut |
700 | 1 | a Cusi, Daniele4 aut |
700 | 1 | a Glorioso, Nicola4 aut |
700 | 1 | a Barlassina, Cristina4 aut |
710 | 2 | a Kardiovaskulär forskning - hypertonib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Journal of Hypertensiong 33:6, s. 1301-1309q 33:6<1301-1309x 1473-5598 |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/25695618?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1097/HJH.0000000000000541y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/5143308 |
856 | 4 8 | u https://doi.org/10.1097/HJH.0000000000000541 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:131177913 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy